Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients

Not yet recruiting

Phase 4 Results N/A

Summary of Purpose

To evaluate whether there is a difference in symptomatic thromboembolism events in the subset of patients with a history of, or risk factors for thromboembolic disease for topically applied tranexamic acid in total joint arthroplasty.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 January 2017.

1 Feb 2016 30 Dec 2015 1 Jan 2019 1 Jan 2019 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts